Delivery Order SPE2DB22D6029-SPE2DB25FLVVW
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,120.74 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,867.90 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cyclophosphamide 500 mg vials, with an ultimate completion date of September 17, 2025. This firm fixed-price contract represents a non-set-aside award issued through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials, valued at $1,120.74. The award, issued on August 19, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.80 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclophosphamide 1 GM/5 ML vials (5 ML quantity). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials under a firm fixed-price contract valued at $1,226.03. This competitively awarded, non-set-aside delivery order was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Cyclophosphamide is a critical chemotherapy agent used in military and federal healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,735.80 contract is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cyclophosphamide 50 mg capsules (100 count) valued at $1,942.93. This is a firm fixed-price delivery order with a completion deadline of September 9, 2025, and no set-aside designation was utilized. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,732,286 units of Cyclophosphamide 2 GM vials, a chemotherapy drug. The $70,284.14 firm-fixed-price contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,118,918 units of the pharmaceutical product Cyclophosphamide 1 GM/5 ML VL 5ML. The order, valued at $1,449.08, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued...
- This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of 4,568,324,077 units of the pharmaceutical drug Cyclophosphamide 2 GM Vials. The $30,981.56 firm fixed-price contract has a completion date of May 22, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery...